RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia | Pharmacogenomics
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Cytarabine-resistant (1280nM) acute myeloid leukemia (AML) MOLM-13 cell line | Cell Lines - Ximbio
Cytarabine Dose for Acute Myeloid Leukemia | NEJM
Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia | PLOS ONE
Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13 | BioTechniques
SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival | Leukemia
Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia | PLOS ONE
Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule. Used in Treatment of Acute Myeloid Leukemia (AML), Acute Stock Illustration - Illustration of lymphocytic, lymphoma: 188460947
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia | Haematologica
Primary AML cells and cell lines resistant to cytarabine, daunorubicin... | Download Scientific Diagram
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Skeletal formula. Stock Illustration | Adobe Stock
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
Apoptosis of AML cells induced by EDO-S101 and Ara-C alone or... | Download Scientific Diagram
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations - Experimental Hematology
Co-administration of Ara-C/metformin induced apoptosis of AML cells.... | Download Scientific Diagram
![PDF] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/094147101525dbcb98a9d514f1a305a20a3a7f7c/3-Table1-1.png "PDF] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. | Semantic Scholar")
PDF] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. | Semantic Scholar
Cytarabine Cytosine Arabinoside, Ara-C Chemotherapy Drug Molecule. Used in Treatment of Acute Myeloid Leukemia AML, Acute. Stock Vector - Illustration of arabinofuranosyl, cancer: 187174096
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Mathematical Models for the Influence of Cytarabine on White Blood Cell Dynamics in Acute Myeloid Leukemia | bioRxiv
Patient-Derived Acute Myeloid Leukemia Models | The Jackson Laboratory
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients - Annals of Oncology
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy
Comparison of Ara-C sensitivity in sensitive and resistant AML cell... | Download Table
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML | Leukemia
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia | Nature Communications
